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ABSTRACT
Ethanol (EtOH) exposure during pregnancy induces cognitive and physiological deficits in the offspring. However, the
role of paternal alcohol exposure (PAE) on offspring EtOH sensitivity and neurotrophins has not received much
attention. The present study examined whether PAE may disrupt nerve growth factor (NGF) and/or brain-derived
neurotrophic factor (BDNF) and affect EtOH preference/rewarding properties in the male offspring. CD1 sire mice were
chronically addicted for EtOH or administered with sucrose. Their male offsprings when adult were assessed for EtOH
preference by a conditioned place preference paradigm. NGF and BDNF, their receptors (p75NTR, TrkA and TrkB),
dopamine active transporter (DAT), dopamine receptors D1 and D2, pro-NGF and pro-BDNF were also evaluated in
brain areas. PAE affected NGF levels in frontal cortex, striatum, olfactory lobes, hippocampus and hypothalamus. BDNF
alterations in frontal cortex, striatum and olfactory lobes were found. PAE induced a higher susceptibility to the EtOH
rewarding effects mostly evident at the lower concentration (0.5 g/kg) that was ineffective in non-PAE offsprings.
Moreover, higher ethanol concentrations (1.5 g/kg) produced an aversive response in PAE animals and a significant
preference in non-PAE offspring. PAE affected also TrkA in the hippocampus and p75NTR in the frontal cortex. DAT was
affected in the olfactory lobes in PAE animals treated with 0.5 g/kg of ethanol while no differences were found on
D1/D2 receptors and for pro-NGF or pro-BDNF. In conclusion, this study shows that: PAE affects NGF and BDNF
expression in the mouse brain; PAE may induce ethanol intake preference in the male offspring.
Keywords Ethanol intake preference, neurotrophin, paternal alcohol exposure.
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INTRODUCTION
A great body of evidence suggests that maternal alcohol
exposure in uteromay be associated with a wide variety of
anomalies in the offspring, such as pre- and postnatal
growth retardation, a distinctive facial dysmorphology,
damage to several organs, including heart, kidney and
skeleton, and central nervous system dysfunction, result-
ing in cognitive deficits, hyperactivity, sleep disturbance,
etc. (Jones1975;Streissguth&O’Malley2000;O’Malley&
Nanson 2002; Abel 2009). A clinically diagnosable
pattern of these effects is termed fetal alcohol syndrome
(FAS) that should not be confused with fetal alcohol
spectrum disorders (FASDs), a condition that describes a
continuum of permanent birth defects caused by mater-
nal consumption of alcohol during pregnancy, which
includes FAS (Astley 2004). Based also on the four-digit
method of diagnosis (Astley 2013), there are also a
number of other subtypes with evolving nomenclature
and definitions settled on partial expressions of FAS,
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including partial fetal alcohol syndrome, alcohol-related
neurodevelopmental disorder, alcohol-related birth
defects, and fetal alcohol effect (Bakoyiannis et al. 2014).
Contrary to the great attention given to the influence
that maternal factors have on the outcome of pregnancy,
little is currently known about the possible role played by
paternal factors, particularly about the influence of pater-
nal alcohol exposure (PAE) on the neurobehavioral and
developmental features of offspring (Abel 2004). It has
been hypothesized that about 75 percent of childrenwith
FAS have heavy drinkers or alcoholic biological fathers
(Abel 2004).These data suggest that the anomalies in the
offspring attributed to the influence of teratogenic effects
of maternal drinking are also the result of the PAE, so the
anomalies may be due to or are exacerbated by paternal
drinking. It has beendemonstrated that offsprings sired by
alcohol-exposed fathers have some difficulty in certain
learning tasks, e.g. passive avoidance (Abel & Dintcheff
1986). Recent studies demonstrated also that PAE can
increase thepercentageof fetuseswith thehumanequiva-
lent of low birth weight (Abel 2004). Other studies estab-
lished that animals sired by alcohol-treated fathers
showed an increase in major malformations or average
fetal or birthweight (Randall et al. 1982; Bielawski &Abel
1997; Abel 1999). It has been also shown that paternal
chronic vapor ethanol reduced ethanol preference and
consumption, enhanced sensitivity to the anxiolytic and
motor-enhancing effects of ethanol compared with
control-sired male offspring (Finegersh & Homanics
2014). Unlike the effects observed as a result of maternal
alcohol exposure, which are probably due to the direct
effect and disruption of normal morphogenesis in the
developing embryo and fetus (Goodlett et al. 1989;
Goodlett & Horn 2001), the effects observed after PAE are
difficult to explain. In this regard, three possible mecha-
nisms have been proposed involving non-genetic, genetic
and epigenetic factors (Abel 2004, 2009).
As for maternal ethanol exposure, important effects
have been shown in brain regions inducing neuronal cell
death in the offspring (Servais et al. 2007), with signifi-
cant changes at the neurotrophin signaling pathways
level (Aloe & Tirassa 1992; Aloe, Bracci-Laudiero &
Tirassa 1993; Aloe 2006; Fiore et al. 2009b,c; Ceccanti
et al. 2012, 2013). Similar to what occurs as a result of
maternal prenatal alcohol exposure, paternal alcohol
consumption could affect biological mediators, such as
neurotrophins, molecules known to play a crucial role in
the survival, development and functionof nervous system
(Sofroniew, Howe &Mobley 2001; Chao, Rajagopal & Lee
2006). Among these, nerve growth factor (NGF) and
brain-derived neurotrophic factor (BDNF) are prominent
growth factors that play a critical role in the physiopathol-
ogy of the brain and cardiometabolic system (Chao 2000;
Fiore, Chaldakov & Aloe 2009a; Yanev et al. 2013). NGF
was the first neurotrophin discovered, about 60 years ago
by Rita Levi-Montalcini and colleagues, as a soluble
protein that promotes the survival and growth of sympa-
thetic and sensory neurons during development (Cohen,
Levi-Montalcini & Hamburger 1954; Levi-Montalcini
1987). Several data then showed that NGF exerts trophic
effects on NGF-responsive neurons, not only during the
development but also in adulthood (Alleva, Aloe & Bigi
1993; Aloe 2001; Aloe, Alleva & Fiore 2002). Despite the
NGF action was once considered limited to central and
peripheral nervous systems, more studies have widely
demonstrated that NGF actions also extended to several
non-neuronal cells. In this regard, NGF can affect the
functioning of the immune-hematopoietic system and it
plays an important role in the maintenance of a balance
betweenneuroendocrine, immune andmetabolic systems
(Aloe et al. 1997; Bonini et al. 2002; Fiore et al. 2009a;
Yanev et al. 2013). Furthermore, BDNF is a growth factor
expressed in a range of tissue and cell types, such as the
central andperipheral nervous system, retina andadipose
tissue (Allen & Dawbarn 2006; Chao et al. 2006; Yanev
et al. 2013). BDNF plays an important role in dendritic
branching and dendritic spine plasticity associated with
learning and memory processes (He et al. 2013;
Bekinschtein, Cammarota & Medina 2014). There is also
evidence showing that the precursors to NGF or BDNF,
pro-NGFandpro-BDNF,mayalsoplay important roles due
to their ‘mixed’ apoptotic and trophic properties
(Hempstead 2014). Both NGF and BDNF are widely
known to play an important role within the pathogenesis
of developmental alcohol exposure since it has been
shown that alcohol exposure during pregnancy disrupts
neurotrophin pathways that in turn affect brain cell
growth and development (Aloe 2006; Fiore et al. 2009b)
with or without the contribution of other mechanisms
leading toFASDonset: i.e. theFASDglutamatergichypoth-
esis (Tsai, Gastfriend & Coyle 1995).
The biological effects of these two neurotrophins are
mediated through activation of the members of the
tropomyosin-related kinase (Trk) family of receptor
tyrosine kinases: NGF activates TrkA, BDNF bind to TrkB
(Freund-Michel & Frossard 2008). Both NGF and BDNF
are able to activate the low affinity p75 neurotrophin
receptor (p75NTR) (Chao & Hempstead 1995; Huang &
Reichardt 2003).
Thus, the aim of the present workwas to investigate in
the mouse the effects of PAE on the NGF and BDNF levels
in the offspring brain and on the expression of their
receptors, TrkA, TrkB and p75NTR. In our study, we
assessed PAE offspring as EtOH-induced preference to
determine whether or not paternal chronic alcohol expo-
sure affects the postnatal experiences on processing of
rewarding and aversive stimuli. We also investigated the
expression of pro-NGF, pro-BDNF and the expression of
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the dopamine active transporter (DAT) and dopamine
receptors D1 and D2 known to have a subtle role in
alcohol dependence and associated rewarding mecha-
nisms (Tabakoff & Hoffman 2013).
MATERIALS AND METHODS
Animals
CD1 outbred male mice were used in this experiment. All
animals were 3 months old and housed singularly at the
beginning of the experiments in Plexiglas cages
(33 × 13 × 14 cm) under standardized conditions with
pellet food (enriched standard diet purchased from
Mucedola, Settimo Milanese, Italy). Food (Purina Lab
Chow #5015) and water were available ad libitum. A
12L:12D lighting regime was used.
Ten male CD1 mice were randomly divided into two
groups: a group of mice (n = 5) received ad libitum, as only
source of liquid, after an habituation period of 10 days,
ethanol 11percent dissolved inwater for 60days; another
group of mice (n = 5) received sucrose dissolved in water
at equivalent caloric intake of the ethanol group and was
used as control group. Ethanol used for the preparation of
the drinking solution was obtained from Sigma-Aldrich
(St. Louis,MO,USA)andwasof analytical grade.Thedaily
consumption of ethanol solution was measured day by
day. Two months after treatment, males were allowed to
breed with non-treated females (n = 10), for 2 hours,
without any source of liquid.Thepresence of a copulation
plug in female mice was presumed to indicate mating. At
birth, all litters were reduced to four males only (Cirulli,
Adriani & Laviola 1997). Pups remained with their own
mother. The experiments were carried out only on the
male offspring (20 offsprings sired by control fathers and
20 offsprings sired by alcohol-exposed fathers). To investi-
gate ethanol consumption preference in the offspring,
60-day-old offsprings were treated i.p. with 0.5 or
1.5 g/kgof ethanol or vehicle (saline solution) to generate
six experimental groups, namely: PAE-Veh;PAE-0.5EtOH;
PAE-1.5 EtOH; non-PAE-Veh; non-PAE-0.5 EtOH; non-
PAE-1.5 EtOH (n = 6 for each experimental group). All
efforts were made to minimize and reduce animal suffer-
ing and for limiting the number of animals used. All ani-
mal experimentswere carried out following the procedure
described in the guidelines of the European Community
Council Directive of 24 November 1986 (86/609/EEC).
Place conditioning
The procedure for evaluating EtOH-induced conditioned
place preference (CPP) has been described previously
(Ventura et al. 2013). The place conditioning apparatus
comprised two Plexiglas chambers (15 × 15 × 20 cm),
one white with a large grid floor and the other black with
a narrow grid floor and a central alley (15 × 5 × 20 cm).
Two sliding doors (4 × 20 cm) connected the alley to the
chambers. In each chamber, two triangular parallelepi-
peds (5 × 5 × 20 cm) made of black Plexiglas and
arranged in different patterns (always covering the
surface of the chamber) were used as conditioned stimuli.
The luminance of the chambers was adjusted so that
visual and tactile cues would not induce unbiased prefer-
ences for a specific chamber. Briefly, on day 1 (pre-
conditioning), PAE or non-PAEmice were placed between
the two chambers free to explore the entire apparatus for
20 minutes. During the following 8 days (conditioning
phase), each mouse was confined daily for 40 minutes
alternately in one of the two chambers. During EtOH con-
ditioning, animals were randomly assigned to receive
EtOH (0, 0.5 or 1.5 g/kg, prepared from 20 percent
ethanol solution in isotonic saline, v/v). For all three
groups (0, 0.5 and 1.5 g/kg), pairings were counterbal-
anced so that for half of each group the unconditioned
stimulus (EtOH) was paired with one of the patterns and
for half with the other (saline). Testing for the expression
of CPP was conducted on day 10 (post-conditioning)
using the pretest procedure during which the total time
spent in each chamber was recorded. Behavioral data
were collected and analyzed by the ‘Etho-Vision’ (Noldus,
the Netherlands) fully automated video tracking system.
The experimental system is recorded by a digital video
camera and the signal digitized (by a hardware device
called ‘framegrabber’) and transmitted tocomputer’sdata
storage. Next, the digital data were analyzed by means of
the Etho-Vision software to obtain the ‘time spent’
(seconds) that was used for each subject as raw data for
preference scores in each sector of the apparatus. CPPwas
determined by plotting the time spent in the EtOH-paired
compartment during the post-conditioning phase
(day 10).
Blood and brain tissue dissection
Animalswere sacrificedbyaguillotine7days after the end
of the behavioral experiments. The blood was collected in
heparin vials and quickly centrifuged at 10 000 rpm for
15 minutes. The brain was quickly removed and tissues
dissected out using a mouse brain matrix (ASI Instru-
ments, Inc. Co., Warren, MI, USA) (Cuello 1983) and
stored at −80°C until used. Brain tissues were then
homogenized and centrifugedat 8500 rpmand the super-
natant used for NGF and BDNF determination and
Western blot analysis.
Blood ethanol levels by gas chromatography/head space
(HS) procedure
Gas chromatography/HS is applied in this research to
determine blood alcohol concentration in whole blood
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samples. In this research, we used a Clarus 600Gas Chro-
matography Perkin Elmer and a TurboMatrix 40 Trap
HeadSpace Sampler Perkin Elmer with FID detector. Ana-
lytical conditions were set up and the method was vali-
dated by a previous study (Macchia et al. 1995). From
each blood sample is collected 100 μl of whole bloodwith
a micropipette and transferred this volume into a gas
chromatography (GC) vial. The gasses that are formed
inside GC vial will be collected in GC to be analyzed. If the
sample is not analyzed in the same day as its collection, it
is important to firmly close the vial to prevent the evapo-
ration of ethanol during time and to conserve the vial
inside of a refrigerator. Standard solutions were set up for
calibration curve at 100, 50, 25, 12.5, 6.2 and 3.1 mg%
of pure ethanol and were obtained by consequent dilu-
tions of pure ethanol in distilled water.
NGF and BDNF determination
NGF and BDNF were measured following indications
previously released (De Nicolo et al. 2013) in the
hippocampus, frontal cortex, olfactory lobes, hypothala-
mus, liver and kidney (n = 4). NGF/BDNF evaluation was
carried out with ELISA kits ‘NGF EmaxTM ImmunoAssay
System number G7631’ and ‘BDNF EmaxTM
ImmunoAssay System number G7611’ by Promega
(Madison, WI, USA) following the instructions provided
by themanufacturer.TheNGF sensitivity of the assaywas
about 3 pg/g of wet tissue and cross-reactivity with other
related neurotrophic factor (BDNF, neurotrophin-3 and
neurotrophin-4) was less than 3 percent. The BDNF sen-
sitivity of the assay was about 15 pg/ml of wet tissue and
cross-reactivity with other related neurotrophic factor
(NGF, neurotrophin-3 and neurotrophin-4) was less than
3 percent. Data are represented as pg/mg total proteins
and all assays were performed in duplicate which were
averaged for statistical comparison.
Western blotting analyses for TrkA, TrkB, p75NTR, DAT,
D1, D2, pro-NGF and pro-BDNF
TrkA, TrkB, p75NTR, DAT, D1, D2, pro-NGF and pro-BDNF
weremeasured in thehippocampus,hypothalamus, olfac-
tory lobes and frontal cortex (n = 4) following methods
previously described (De Nicolo et al. 2013). Aliquots
(30 mg) from total tissue lysate proteins were resolved
on 10 percent SDS-PAGE gels and analyzed by
immunoblottingwith the following antibodies: anti-TrkA
1:1000 (provided by Santa Cruz, CA, USA, catalog
number: 763:sc-118), anti-TrkB 1:1000 (provided by BD
Biosciences Pharmingen, San Jose, CA, USA, catalog
number: 610102), anti-p75NTR 1:1000 (provided by
Cell Signaling, Danvers, MA, USA, catalog number:
8238), anti-DAT (provided by Millipore, Billerica, MA,
USA, catalog number: AB1591P), anti-D1 1:1000
(provided by Abcam, Cambridge, UK, catalog number:
AB20066), anti-D21:1000 (provided byMerckMillipore,
Billerica,MA,USA, catalognumber:AB5084P), anti-pro-
NGF 1:1000 (provided by Alomone Labs, Israel, catalog
number:ANT-005)oranti pro-BDNF1:2000(providedby
Millipore, catalog number: AB5613P). The secondary
antibodies used were as follows: horseradish peroxidase-
conjugated anti-rabbit IgG or anti-mouse IgG (Cell Signal-
ling, Beverly, MA, USA). The blots were developed
with enhanced chemiluminescence assay (Amersham
Bioscience, Amersham, UK), following the instructions of
the manufacturer.
Statistical analysis
Data were analyzed by two-way ANOVAs considering as
factors the paternal ethanol exposure and the ethanol
treatment. Post hoc comparisons were performed using
the Bonferroni’s test.
RESULTS
General description of the PAE mouse model
Ethanol drinking did not elicit changes in the bodyweight
of fathers, indeed at the time of mating there were not
significant differences in bodyweight between the ethanol
groupof sires and the sucrosegroup (49.33 ± 2.21versus
47.97 ± 1.33, respectively). Liquid and food consumption
of ethanol-exposed fathers and control fathers were also
similar between groups. In the ethanol group of fathers, a
careful day-by-day measurement of liquid consumption
indicated that values of ethanol intake are comprised of
0.15 and 0.26 ml with a mean daily consumption of
0.20 ± 0.018 ml. The blood ethanol levels in the ethanol-
exposed sires 1 day after mating, expressed asmg/100 ml
of mouse blood, were comprised of 3.5 and 21.5 mg/
100 ml.As for thePAEoffsprings, no differences in perina-
tal mortality, numbers of pups (litter size) and numbers of
dead-born pups were observed. Quite interestingly, PAE
offsprings had significant lower values of body weight as
shownat the timeof mouse sacrificewhen comparedwith
the body weight values of controls offspring without any
effects of ethanol treatment (42.88 ± 0.65 versus
47.24 ± 0.69 g; P < 0.05 in the ANOVA for the effect of
ethanol administration).
NGF determination
Figure 1 shows the results of the ELISA for NGF
(expressed as pg/mg total protein) in the offspring sired by
alcohol-treated fathers or sucrose control fathers. In the
cortex, data show lower NGF levels in PAE-0.5 EtOH but
highest levels in non-PAE-Vehicle (Ps < 0.05 for the
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effects of PAE, ethanol treatment and PAE × ethanol
treatment interaction; see post hocs for differences
between groups). In the hippocampus, ANOVA revealed
the effect of PAE due to the low NGF levels in PAE-0.5
EtOH mice (P < 0.01 for the PAE effect, P < 0.05 in post
hocs). In the olfactory lobes, data showed effects of both
PAE and ethanol administration (Ps < 0.01 for the effects
of PAE and ethanol treatment; see post hocs for differences
between groups). In the hypothalamus, ANOVA revealed
the effect of PAE due to the lowNGF levels in both PAE-0.5
EtOH and PAE-1.5 EtOHmice (P < 0.01 for the PAE effect,
P < 0.05 in post hocs). Quite interestingly, in the liver NGF
levels were higher in PAE-1.5 EtOH animals when com-
pared with the respective non-PAE (P < 0.05 for the
interaction PAE × ethanol treatment; see post hoc for dif-
ferences between groups). Similar results were found in
the kidneywith a NGF potentiation in PAE-1.5 EtOHmice
compared with their non-PAE (Ps < 0.01 for the effects of
ethanol treatment and PAE × ethanol treatment interac-
tion; see post hocs for differences between groups). No
significant differences between groups were observed in
the testis (data not shown).
Figure 1 NGF levels expressed as pg/g proteins in selected areas (frontal cortex, hippocampus, olfactory lobes hypothalamus, kidney and
liver) of male mice sired by control fathers or alcohol-exposed fathers and treated i.p. with 0.5 or 1.5 g/kg of ethanol or vehicle (PAE-Veh;
PAE-0.5 EtOH; PAE-1.5 EtOH; controls-Veh; controls-0.5 EtOH; controls-1.5 EtOH).The vertical lines in the figure indicate pooled standard
error means (SEM) derived from appropriate error mean square in the ANOVA. Asterisks indicate significant differences between groups
(*P < 0.05)
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BDNF determination
Figure 2 shows the results of the ELISA for BDNF
(expressed as pg/mg total protein) in the offsprings sired
by alcohol-treated fathers or sucrose control fathers. In
the cortex, data show higher BDNF levels in PAE-Veh
compared with the other groups (Ps < 0.05 for the effects
of PAE, ethanol treatment and PAE × ethanol treatment
interaction; see post hocs for differences between groups).
In the olfactory lobes, ANOVA revealed a modulation due
to ethanol administration in PAE animals with higher
concentrations in PAE-Veh compared with the other
PAE groups (Ps < 0.01 for the effects of both PAE and
ethanol administration; P < 0.05 in post hocs). In the
hippocampus, data showed an effect of ethanol adminis-
tration with low levels in the 0.5 groups (P < 0.05 for the
effects of ethanol treatment). In the hypothalamus, no
differences between groups were found. In the liver,
ANOVA just failed full significance for a BDNF decrease
due to PAE (P = 0.0569 for the effect of PAE). In the
kidney, a BDNF potentiation was found in non-PAE-Veh
animals compared with the other groups (Ps < 0.05 for
the effects of both PAE and ethanol treatment; see
post hocs for differences between groups). No significant
Figure 2 BDNF levels expressed as pg/g proteins in selected areas (frontal cortex, hippocampus, olfactory lobes hypothalamus, kidney and
liver) of male mice sired by control fathers or alcohol-exposed fathers and treated i.p. with 0.5 or 1.5 g/kg of ethanol or vehicle (PAE-Veh;
PAE-0.5 EtOH; PAE-1.5 EtOH; controls-Veh; controls-0.5 EtOH; controls-1.5 EtOH).The vertical lines in the figure indicate pooled standard
error means (SEM) derived from appropriate error mean square in the ANOVA. Asterisks indicate significant differences between groups
(*P < 0.05)
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differences between groups were observed in the testis
(data not shown).
Western blotting analyses for TrkA, TrkB, p75NTR, DAT,
D1, D2, pro-NGF and pro-BDNF
Protein tissue extracts have been used to analyze (by
Western blot) the expression of NGF and BDNF receptors
(TrkA, TrkB and p75NTR), pro-NGF/pro-BDNF, dopamine
receptors (D1 and D2) and the dopamine transporter
(DAT) in different brain areas, such as: hippocampus,
hypothalamus, frontal cortex and olfactory lobes. The
data obtained by densitometric analysis in the offspring
sired by alcohol-treated fathers or sucrose control fathers
showedno significant differences in theprotein expression
of NGF and BDNF receptors, except for TrkA in the
hippocampus and p75NTR in the frontal cortex (Fig. 3). In
the hippocampus (Fig. 3a), data showed higher TrkA
expression in all PAE groups compared with respective
non-PAE groups (P < 0.05 for the effects of PAE in the
ANOVA, see post hocs in the table for differences between
groups). In the frontal cortex (Fig. 3b), data evidenced low
p75NTR expression in non-PAE-1.5 EtOH, in PAE-Veh and
in PAE-0.5 EtOH when compared with non-PAE-Veh
(P = 0.01 in theANOVA for the interaction PAE × Ethanol
administration; see post hocs comparison in the table for
the differences between groups). As for the expression of
DAT (Fig. 3c), ANOVA revealed that the administration of
0.5 of ethanol elicited a strong DAT potentiation in the
olfactory lobes (P < 0.01 for the effect of ethanol admin-
istration; see post hocs in the table for differences between
groups). No differences were found in the protein expres-
sionof D1andD2 receptors in brain tissues or for pro-NGF
and pro-BDNF (data not shown).
Place conditioning
The effects of EtOH-elicited preference in PAE or non-PAE
male offsprings are shown in Fig. 4a and b, respectively.
There was no statistically significant difference in prefer-
ence for one chamber of the apparatus in control or EtOH
groups during the pretest session (data not shown). For
post-conditioning session in PAE offspring, the repeated
measures ANOVA evidenced a significant EtOH × pairing
interaction (P < 0.01).Post hocanalysis revealed the exist-
ence of a significant preference for the EtOH-paired com-
partment only in mice conditioned with the lower dose of
EtOH (0.5 mg/kg; Fig. 4a), while mice conditioned to the
higher dose of EtOH (1.5 mg/kg) showed a significant
increase in preference toward the EtOHunpaired (Fig. 4a)
and therefore no preference when the compartment was
paired to the higher dose tested. For post-conditioning
session in non-PAE offspring, the repeated measure
ANOVA showed a significant EtOH × pairing interaction
(P < 0.001). Post hoc analysis further revealed a signifi-
cant preference for the EtOH-paired compartment only in
the non-PAE offspring conditionedwith the higher dose of
EtOH(1.5 mg/kg;Fig. 4b),while theoffspringconditioned
to the lower dose of EtOH (0.5 mg/kg) showed no differ-
enceas comparedwith the control group (Fig. 4b). Finally,
there were no significant differences in locomotion
between control and EtOH-conditioned mice during the
conditioning phase (data not shown).
DISCUSSION
This is the first study to demonstrate that PAE affects NGF
(Fig. 1) and BDNF (Fig. 2) levels in targeted brain regions
and peripheral tissues from mice offspring and enhances
the sensitivity to the rewarding effects of EtOH adminis-
tration in male progeny. Our data provide evidence that
EtOH-sired male offspring displayed a CPP to an environ-
ment paired with a non-reinforcing dose of EtOH (0.5 g/
kg). The PAE-induced lowering of reward threshold to
EtOH effects in mice offspring is further underlined by the
aversive response induced by the higher EtOH dose
(1.5 g/kg). Thus, the EtOH dose eliciting a maximal place
conditioning effect in the offspring of non-PAE mice pro-
duced a conditioned place aversion in the offspring of PAE
mice, while a subthreshold dosage in non-PAE mice off-
spring produced a rewarding effect in male offspring of
alcoholic fathers.
Our study provides evidence that PAE may affect the
levels of key trophic factors as NGF and BDNF in the
offspring brain, affecting also TrkA in the hippocampus
and p75NTR in the frontal cortex. Our data show that
NGF is a neurotrophin particularly vulnerable to alcohol-
induced transgenerational neuronal damage.We found a
marked decrease in NGF expression in the frontal cortex
of male offspring from PAE mice, as compared with off-
spring from non-PAE animals, regardless of the dose of
EtOH administrated (Fig. 1a). However, NGF levels also
showed higher susceptibility to EtOH administration at
hippocampal, hypothalamic and olfactory lobe levels
(Fig. 1b, c and e). Indeed, 8 days of EtOH administration
was sufficient to reduce the NGF expression in these brain
areas below the level showed by the untreated offspring
from PAE mice. Notably, the lower the dose of EtOH
administered, the greater the reduction of NGF expres-
sion detected. In this regard, the increased sensitivity to
rewarding effects of EtOH administration appears
inversely related to the levels of NGF expressed in the
frontal cortex, hippocampus, hypothalamus and olfac-
tory lobes. By contrast, BDNF levels were increased only
in the frontal cortex of PAE offspring that did not receive
any EtOH treatment. Higher levels of BDNF mRNA
expression have been detected in the amygdala and
ventral tegmental area of alcohol preferring animals
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(Raivio, Miettinen & Kiianmaa 2014) and chronic EtOH
vapor-induced PAE was shown to increase the expression
of BDNF in the ventral tegmental area of the offspring
(Finegersh & Homanics 2014). Our results appear to
support an increase in BDNF expression in the frontal
cortex of PAE offsprings, while EtOH administration
reduced the BDNF expression to levels comparable to
those showed by the non-PAE male offspring.
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Figure 3 Densitometric analysis and gel expression of TrkA in the hippocampus (a), p75NTR in the frontal cortex (b), and DAT in the olfactory
lobes (c) of male mice sired by control fathers or alcohol-exposed fathers and treated i.p. with 0.5 or 1.5 g/kg of ethanol or vehicle. Gel
densitometric analysis has been carried out by using the public domain ‘Image J’ software (http://imagej.nih.gov/ij/).The vertical lines in the figure
indicate pooled standard error means (SEM) derived from appropriate error mean square in the ANOVA. Asterisks indicate significant
differences between groups (*P < 0.05)
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Although the impact of paternal alcoholism may not
be as great as that associated with maternal alcoholism,
our data strongly suggest that it should not be underval-
ued, thus indicating that paternal alcohol consumption
produced key and permanent changes in the offspring’s
brain. Several studies support the view that paternal con-
sumption of alcohol is associated with developmental
abnormalities. PAE seems to be associated with signifi-
cant changes in infant birthweight and ventricular septal
defects (Little & Sing 1987; Tarter, Jacob & Bremer 1989;
Passaro et al. 1998). Moreover, it has been shown that
chronic paternal alcohol abuse causes cognitive impair-
ment and hyperactivity, even in children raised by non-
drinker adoptive fathers (Hegedus, Alterman & Tarter
1984; Tarter et al. 1989). Some reports from rodent
studies evidenced that PAE may elicit developmental
abnormalities, as changes in organ weights including the
brain (Tanaka, Suzuki & Arima 1982; Abel 1993), thick-
ening of cortical layers (Jamerson, Wulser & Kimler
2004), and reduction in testosterone levels (Abel 1989)
and also behavioral abnormalities as decreased displace-
ment behavior in response to novel environments or
stressful events (Abel 1991), altered spatial learning per-
formances (Wozniak et al. 1991), and altered immobility
in a forced swim test (Abel & Bilitzke 1990). Notably, such
alterations did not result to be associated with father’s
stress and/or malnutrition due to PAE. However, other
studies found no decreases in implantation sites or fetal
weight, and no increases in prenatal mortality (Randall
et al. 1982; Passaro et al. 1998) or soft tissue malforma-
tions (Randall et al. 1982) or any effect on brain or pla-
cental weight (Cake & Lenzer 1985).
In contrast to the paucity of data on PAE and
neurotrophins, the effects of maternal alcohol consump-
tion during pregnancy on neurotrophins have received
much greater attention and generated multiple lines of
evidence. Findings from different laboratories have
shown changes in NGF and BDNF and their receptors in
most of the brain areas including cortex, hippocampus,
striatum, hypothalamus, olfactory lobes and cerebellum
and in target organs of EtOH intoxication (e.g. liver),
regardless of the route of EtOH administration during
pregnancy (vapor; parenteral administration; drinking
water). These NGF/BDNF changes were also associated
with behavioral alterations in offspring, such as in
memory and learning abilities and sensitivity to EtOH
consumption (Naassila et al. 2003; Aloe 2006;
Hellemans et al. 2008, 2009; Fiore et al. 2009b; Ceccanti
et al. 2012, 2013). Quite interestingly, the changes in
neurotrophins and related behavioral parameters
observed in PAE animal models and in other FASD animal
models appear to be comparable, leading to the possibility
that ethanol may disrupt brain cells directly, throughout
its metabolites, by the way of ethanol-induced oxidative
stress and/or genetic-epigenetic pathways.
Neurotrophins can modulate neuroadaptations in
addictive behavior and alcohol consumption is influenced
by the interaction between BDNF and dopamine (DA)
transmission (Bosse & Mathews 2011). It has been
shown that EtOH exposure in sire mice may induce
ADHD-like (attention deficit hyperactivity disorder)
effects such as hyperactive, inattentive and impulsive
behaviors in the offspring (Kim et al. 2014). Alterations of
the DA signaling and DAT are commonly associated with
ADHD, and an increased methylation of a CpG region of
the DAT gene promoter in PAE animals is reported as
potential epigenetic signature underlying the decrease of
DAT protein andmRNA expression in cerebral cortex and
striatum of PAE offspring (Kim et al. 2014).
In our hands, animals were sacrificed 1 week after
place conditioning and, nevertheless, neurotrophins and
DAT levels were shown to be affected by EtOH treatment.
The rate at which DAT removes DA from the synapse can
have a profound effect on DA signaling. This is best evi-
Figure 4 EtOH-induced conditioned place preference (CPP) is dif-
ferently modulated in PAE (a) and non-PAE (b) male offspring. (a)
PAE offspring showed a significant increase in preference scores
(seconds) for the EtOH-paired side (0.5 g/kg) while a significant
increase in preference scores (seconds) for the EtOH-unpaired side
(1.5 g/kg). (b) Non-PAE offspring showed a significant increase in
preference scores (seconds) for the EtOH-paired side (1.5 g/kg) but
no EtOH-induced preference (0.5 g/kg). Data are presented as
mean ± SEM. *EtOH 0 g/kg versus EtOH 0.5 g/kg (a, paired side);
*EtOH 0 g/kg versus EtOH 1.5 g/kg (b, paired side); #EtOH 0.5 g/kg
versus EtOH 1.5 g/kg (a and b, paired side); °EtOH 0 g/kg versus
EtOH 0.5 g/kg or 1.5 g/kg (a, unpaired side). Tukey’s post hoc test
(P < 0.05)
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denced by the severe cognitive deficits and hyperactivity
of mice with no DA transporters (Van der Kooij &
Glennon 2007). We found a potential inverse relation-
ship between EtOH doses and levels of DAT expression in
olfactory lobes of male offspring from PAE mice (Fig. 3c).
Thus, DAT expression was increased in animals that
received 0.5 g/kg EtOH, although the magnitude of DAT
expression did not differ from that showed by offspring
from non-PAE mice treated with the same EtOH dose.
Despite the lack of difference between DAT expressions in
offspring from PAE or non-PAE animals, these effects
appear the consequence of the tendency toward an
increase in DAT expression in offspring from PAE mice
that did not receive any EtOH administration. DAT func-
tion is implicated in a number of DA-related disorders,
including clinical depression and alcoholism (Getachew
et al. 2010). DA neurotransmission plays an important
role in EtOH consumption and alcohol-seeking behavior
(for review, see Söderpalm & Ericson 2013). EtOH intake
potentiates DA release from ventral tegmental area
dopaminergic (DAergic) neurons and increases DA
extracellular levels in the nucleus accumbens (Koob
2014). Moreover, DAergic agents and lesion of the DA
systemmodify EtOH self-administration, thus confirming
a specific role for DA in EtOH reward (Di Chiara 1997).
Olfactory lobes are a key limbic structure and the greatest
sensitivity to variations in the total amount of DAT
protein was observed with the same low dose eliciting the
EtOH-induced rewarding effects. Consequently, these
data support the view that EtOH reward and EtOH-
seeking behavior of PAE male offspring may be positively
associated with the amount of DAT protein and, likely,
with reduced DA in the olfactory bulb. In this regard, the
reduction in DA levels is reminding of the withdrawal
syndrome hypothesis and withdrawal-induced decrease
in DA transmission, as the neural correlate of increasing
motivation to EtOH-seeking behavior (Koob 2014).
Hence, adult male offsprings from PAE seem to exhibit
some of the neuroadaptations (i.e. changes in NGF, BDNF
and DA signaling) known to produce changes in sensitiv-
ity to EtOH-mediated effects (withdrawal symptoms) fol-
lowing chronic exposure and discontinuation to alcohol
intake.
As previously observed, the findings of the present
study indicate that alcohol drinking behavior may be
epigenetically transferred through the father lineage. Our
working hypothesis posits that alcohol is an epimutagen
determining specific long-lasting changes affecting the
next generations and their alcohol abuse, although the
ethanol mechanism of action as epimutagen is not fully
known at least in PAE. However, several FASD studies
indicate that this spectrum of disorders due to prenatal
ethanol arises from a complex interplay of genetic and
epigenetic factors (reviewed inMead & Sarkar 2014). The
present results demonstrate a direct impact of PAE on
basal NGF and BDNF levels in target tissues of EtOH
intoxication and the lowering of the threshold to EtOH-
elicited rewarding effects in male offspring although a
limitation of the present study may be represented by the
small number of experimental subjects used in the
testings (as in any animalmodel study) that could have in
some way affected the results.
In conclusion, since EtOH consumption before and at
the time of procreation is a key factor in healthy child
development, the present study may represent a step
forward in the attempt to disclose some biomolecular pro-
cesses and behavioral responses to rewarding outcomes
underlying the transgenerational effects of alcohol
intoxication. Therefore, these results may be of interest
for the investigation of human addiction and in particu-
lar for those interested in the epigenetic programming via
the paternal lineage.
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